A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants

NCT05225207 · clinicaltrials.gov ↗

COMPLETED

Status

658

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Neoplasms
Carcinoma, Hepatocellular

Interventions

OTHER: Non-interventional

Sponsor

Eisai Korea Inc.